A detailed history of Cardinal Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cardinal Capital Management, Inc. holds 196,491 shares of ABBV stock, worth $33.7 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares
196,491
Previous 200,052 1.78%
Holding current value
$33.7 Million
Previous $31 Million 15.42%
% of portfolio
1.76%
Previous 1.63%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

SELL
$159.82 - $182.1 $569,119 - $648,458
-3,561 Reduced 1.78%
196,491 $35.8 Million
Q4 2023

Feb 23, 2024

BUY
$137.6 - $154.97 $72,240 - $81,359
525 Added 0.26%
200,052 $31 Million
Q3 2023

Oct 12, 2023

BUY
$133.59 - $154.65 $193,304 - $223,778
1,447 Added 0.73%
199,527 $29.7 Million
Q2 2023

Jul 10, 2023

BUY
$132.51 - $164.9 $55,654 - $69,258
420 Added 0.21%
198,080 $26.7 Million
Q1 2023

Apr 06, 2023

BUY
$144.61 - $166.54 $3.55 Million - $4.09 Million
24,546 Added 14.18%
197,660 $31.5 Million
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $730,553 - $876,125
5,282 Added 3.15%
173,114 $28 Million
Q3 2022

Oct 07, 2022

BUY
$134.21 - $153.93 $531,471 - $609,562
3,960 Added 2.42%
167,832 $22.5 Million
Q2 2022

Jul 13, 2022

BUY
$137.62 - $174.96 $1.62 Million - $2.06 Million
11,777 Added 7.74%
163,872 $25.1 Million
Q1 2022

Apr 12, 2022

BUY
$131.98 - $163.75 $18.2 Million - $22.6 Million
137,885 Added 970.34%
152,095 $24.7 Million
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $16,114 - $20,389
150 Added 1.07%
14,210 $1.92 Million
Q3 2021

Oct 07, 2021

BUY
$106.4 - $120.78 $237,591 - $269,701
2,233 Added 18.88%
14,060 $1.52 Million
Q2 2021

Jul 09, 2021

BUY
$105.21 - $117.21 $21,252 - $23,676
202 Added 1.74%
11,827 $1.33 Million
Q1 2021

Apr 14, 2021

BUY
$102.3 - $112.62 $145,777 - $160,483
1,425 Added 13.97%
11,625 $1.26 Million
Q4 2020

Jan 15, 2021

BUY
$80.49 - $108.67 $35,818 - $48,358
445 Added 4.56%
10,200 $1.09 Million
Q3 2020

Oct 13, 2020

BUY
$85.91 - $100.83 $39,948 - $46,885
465 Added 5.01%
9,755 $854,000
Q2 2020

Jul 08, 2020

BUY
$73.37 - $98.18 $154,443 - $206,668
2,105 Added 29.3%
9,290 $912,000
Q1 2020

Apr 08, 2020

BUY
$64.5 - $97.79 $421,185 - $638,568
6,530 Added 996.95%
7,185 $547,000
Q4 2019

Jan 15, 2020

BUY
$72.13 - $90.25 $47,245 - $59,113
655 New
655 $58,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cardinal Capital Management, Inc. Portfolio

Follow Cardinal Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management, Inc. with notifications on news.